Neurodegeneration – Products

AMSBIO now offers high-purity, lyophilized exosome standards to enhance reproducibility in extracellular vesicle research.

Quanterix Corporation's Simoa HD-X Immunoassay Analyzer has been granted Class 1 Medical Device registration by South Korea’s Ministry of Food and Drug Safety.

Enhanced Genomics partners with ALBORADA Drug Discovery Institute to identify novel Alzheimer’s drug targets using 3D multi-omics.

Thermo Fisher launches the Orbitrap Astral Zoom and Orbitrap Excedion Pro MS at ASMS 2025, advancing proteomics and drug development.

Thermo Fisher introduces next-gen mass spectrometry solutions at ASMS, designed to accelerate research in multiple scientific fields.

Seer launches Proteograph ONE, doubling throughput and cutting costs for deep, scalable proteomics.

Thermo Fisher’s TruNarc Delta and Tau analyzers enhance law enforcement’s ability to identify over 1,200 narcotics quickly and accurately, even in the field.

Revvity launches the IDS i20™ platform, automating chemiluminescence immunoassays for multiple diagnostic specialties, increasing throughput and flexibility.

ELRIG announces Prof Heather Pinkett and Dr Dafydd Owen as keynote speakers for Drug Discovery 2025, featuring 200+ exhibitors and 150+ talks.

Aptamer Group plc is pleased to announce the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA).